Novo Nordisk - Richard's Trades

Earnings

Novo Nordisk Crushes Q1 Forecasts—But Slashes 2025 Outlook Anyway

Despite record-breaking Q1 earnings from Wegovy and Ozempic sales, Novo Nordisk mysteriously slashes its 2025 outlook. What’s really going on?

Richard's Trades Team
May 8, 2025

Business News

Why Novo Nordisk (NVO) Might Be Wall Street’s Most Underrated Biotech Powerhouse

Novo Nordisk is the biotech world’s quiet giant, quietly dominating diabetes and obesity care. Why is Wall Street overlooking this powerhouse? The shocking truth is waiting to be revealed.

Richard's Trades Team
April 23, 2025

Central Banks

Could Europe’s Euro Dethrone the Dollar? Lagarde Hints at a Global Power Shift

While Europe dreams big, harsh realities keep the euro from challenging the dollar's…

Richard's Trades Team
June 12, 2025

Commodities

Steel and Aluminum Prices Soar as Trump Tariffs Rattle Markets and Sink Industry Stocks

Trump's tariffs send steel prices skyrocketing to $900 per ton while mining stocks…

Richard's Trades Team
June 12, 2025

Nvidia

Amazon Blindsides Nvidia With Bold AI Chip Strategy That Threatens Market Control

Amazon's AI chip strategy could end Nvidia's reign with 40% cheaper processors and…

Richard's Trades Team
June 12, 2025

Crypto

Cathie Wood’s $500M Bet on Circle Sparks Comeback Buzz—Is ARK’s Gamble Paying Off?

Cathie Wood's $373M Circle gamble transforms into a $500M fortune as skeptics eat crow.…

Richard's Trades Team
June 12, 2025